Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Skin perception after intradermal application of IncobotulinumtoxinA
2020-001318-39Phase 2Completed
- Sponsor
- University of Hamburg
- Start
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in Not applicable, sponsored by University of Hamburg. Primary endpoint: Change in skin surface roughness parameters (primary). Started Mar 2021; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2020-001318-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001318-39.